LaBelle has been investing in healthcare companies for over 16 years. Rockman started his career at J. His time at J.
Chief Executive Officer Dr. Schenkein joined Agios in August as the chief executive officer and a member of our board of directors and has been a hematologist and medical oncologist for more than 20 years. He currently serves as an adjunct attending physician in hematology at Tufts Medical Center.
Prior to joining Agios, from March to JulyDr.
While at Genentech, he served as an adjunct clinical professor of medical oncology at Stanford University School of Medicine. Prior to joining Genentech, he served as the senior vice president of clinical research at Millennium Pharmaceuticals, Inc.
He currently serves on the board of directors of Foundation Medicine, Inc. Schenkein holds a B. Chief Scientific Officer Dr. Biller joined Agios as chief scientific officer in Septemberwith more than 25 years of drug discovery and development experience. Prior to that, Dr. Among his other key leadership positions at BMS, Dr.
Biller was the executive director of metabolic diseases chemistry. Biller earned a B. Chief Medical Officer Dr. Bowden joined Agios as chief medical officer in May He has more than 18 years of experience in clinical drug development, including the approval of several cancer medicines.
Prior to joining Agios, Dr. Bowden was vice president product development oncology, franchise lead Signaling Group at Genentech, Inc.
From toDr. In this role, he led medical affairs strategies for cancer, immunology and pain medicines. Prior to his industry experience, Dr. Bowden was on the oncology faculty at the University of Virginia Health Science Center where he participated in numerous industry and cooperative group trials.
Bowden is board certified in internal medicine and medical oncology, and he serves on the board of directors at miRagen Therapeutics. Hirsch joined Agios as chief financial officer in September He has more than 20 years of experience in a range of strategic and operating roles in business, including over 15 years in the biotech industry, most recently having served as president and chief executive officer of BIND Therapeutics.
Hirsch was chief financial officer at Avila Therapeutics until its acquisition by Celgene. He currently serves on the board of directors at Editas Medicine.Steve's offers personalised service and his alert accuracy is highly commendable.
Made a recent gain of % from AAPL Calls thanks to him. Will not hesitate to recommend grupobittia.com for those who wants to learn and profit from Options.
Registration to SRI-CONNECT is limited to people with a direct, active and professional interest in Sustainable & Responsible Investment. Please do not register unless this describes you. View Lisa Short’s profile on LinkedIn, the world's largest professional community.
Lisa has 9 jobs listed on their profile. See the complete profile on LinkedIn and discover Lisa’s connections and . View Amanda Kho’s profile on LinkedIn, the world's largest professional community.
Amanda has 4 jobs listed on their profile. See the complete profile on LinkedIn and discover Amanda’s connections and jobs at similar grupobittia.com: Business Planning Analyst at . Support overall Business Planning and Analysis processes by leading and coordinating activities such as monthly reporting, quarterly forecasting, annual budget Title: Business Planning Analyst - .
Business Analyst - Novartis. Jobs, companies, people, and articles for LinkedIn’s Business Analyst - Novartis members Business Planning Analyst at Novartis Ecuador S.A. Area Business.